TrovaGene Inc news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

TROV 0.980 +0.020 (2.08%)
price chart
Trovagene, Inc. Regains Compliance with NASDAQ Listing Requirements
SAN DIEGO, July 10, 2017 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced that it received notice from The NASDAQ Stock Market LLC (NASDAQ) indicating that the Company has regained ...
Trovagene Inc (NASDAQ:TROV) Quarterly Sentiment Report  Weekly Register
Trovagene Announces Agreement with Novogene for NextCollect™ in China
SAN DIEGO, July 12, 2017 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), today announced that they have entered into an agreement with Novogene Co.
Trovagene Announces Expansion of Key Claims for its NPM1 Patent Portfolio for ...
SAN DIEGO, June 26, 2017 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced that the U.S.
Trovagene Announces Manufacturing Agreement with NerPharMa for Supply of PCM ...
SAN DIEGO, June 29, 2017 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced it has executed a supplier agreement with NerPharMa, S.r.
Trovagene Engages Leading CRO in AML to Conduct Phase 1b/2 Trial of PCM-075
SAN DIEGO, July 6, 2017 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, announced today that is has formally engaged PRA Health Sciences, a leading, global contract research organization (CRO), ...
Trovagene receives default notice from lender; shares down 8%
Nano cap Trovagene (TROV -7.9%) slumps on increased volume in response to an 8-K filed today. The company reports that it received a default notice from lender Silicon Valley Bank on June 20 related to a $1.4M loan for equipment dated November 17, ...
Stock Volatility Risk Alert: TrovaGene Inc Stock Volatility Hits An ...  CML News
Buy or Sell? Average Brokerage Ratings on Endocyte, Inc. (ECYT), TrovaGene ...  StockNewsJournal
Which Way Traders Signposts TrovaGene, Inc. (TROV), American Express Company ...
Investors who are keeping close eye on the stock of TrovaGene, Inc. (NASDAQ:TROV) established that the company was able to keep return on investment at -96.32 in the trailing twelve month while Reuters data showed that industry's average stands at ...
Analytical Report on TrovaGene, Inc. (TROV)  FactsReporter
TrovaGene Inc (NASDAQ:TROV) Gaps Lower On $7.1 Million Direct Offering  StockNewsUnion
TrovaGene Inc (NASDAQ:TROV) And Novogene Enter Agreement Over Nextcollect
Novogene has revealed that it is entering into a deal with TrovaGene Inc (NASDAQ:TROV), a firm focusing on precision medicine biotechnology with a view to acquiring NextCollect, a proprietary device for nucleic acid preservation and urine collection.
Popular Stock to Observe: TrovaGene, Inc. (TROV)  StandardOracle
Selected Notes From Analysts On TrovaGene, Inc. (TROV)  AllStockNews
TrovaGene, Inc. (NASDAQ:TROV) Given a $4.00 Price Target at Maxim Group
TrovaGene logo TrovaGene, Inc. (NASDAQ:TROV) received a $4.00 price objective from stock analysts at Maxim Group in a research note issued to investors on Tuesday, June 27th.
Is TrovaGene, Inc. (NASDAQ:TROV) ready to Pivot? Share Update  FLBC News
Investors Are Keeping an Eye on Shares of Trovagene Inc (TROV)  Financial News Review
Today's Brokerage Rating: EQT Corporation (EQT), TrovaGene, Inc. (TROV)
TrovaGene, Inc. (NASDAQ:TROV), maintained return on investment for the last twelve months at -96.32, higher than what Reuters data shows regarding industry's average.
TrovaGene Inc Risk Points versus Health Care  CML News
TrovaGene Inc (NASDAQ:TROV) Rallies on NextCollect China Deal and NASDAQ ...  StockNewsUnion